Patients’ findings after COVID-19 infection and vaccinations: what to expect from [18F]FDG PET/CT Martina SolliniFabrizia GelardiArturo Chiti Editorial 20 December 2021 Pages: 791 - 795
Firefly luciferase offers superior performance to AkaLuc for tracking the fate of administered cell therapies Francesco AmadeoAntonius PlaggeArthur Taylor Original Article Open access 27 July 2021 Pages: 796 - 808
Noninvasive assessment of coronary microvascular dysfunction using SPECT myocardial perfusion imaging and myocardial perfusion entropy quantification in a rodent model of type 2 diabetes Adrien CarabelliMarjorie CanuLaurent M. Riou Original Article 21 August 2021 Pages: 809 - 820
Eribulin improves tumor oxygenation demonstrated by 18F-DiFA hypoxia imaging, leading to radio-sensitization in human cancer xenograft models Tomoki BoHironobu YasuiYuji Kuge Original Article 01 September 2021 Pages: 821 - 833
Two experts and a newbie: [18F]PARPi vs [18F]FTT vs [18F]FPyPARP—a comparison of PARP imaging agents Sophie StotzJohannes KinzlerAndreas Maurer Original Article Open access 06 September 2021 Pages: 834 - 846
RGD-functionalised melanin nanoparticles for intraoperative photoacoustic imaging-guided breast cancer surgery Jing-Jing LiuZun WangGuo-Jun Zhang Original Article Open access 10 September 2021 Pages: 847 - 860
ImmunoPET of trophoblast cell-surface antigen 2 (Trop-2) expression in pancreatic cancer Weiyu ChenMiao LiWeibo Cai Original Article 14 September 2021 Pages: 861 - 870
Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer model Yuwei LiuTadashi WatabeFrederik Giesel Original Article Open access 18 September 2021 Pages: 871 - 880
An [18F]FDG-PET/CT deep learning method for fully automated detection of pathological mediastinal lymph nodes in lung cancer patients David WallisMichaël SoussanIrène Buvat Original Article Open access 14 September 2021 Pages: 881 - 888
Myocardial perfusion SPECT findings in postCOVID period Mine ArazÇiğdem SoydalElgin Özkan Original Article 07 September 2021 Pages: 889 - 894
International consensus on the use of tau PET imaging agent 18F-flortaucipir in Alzheimer’s disease Mei TianA. Cahid CivelekMolecular Imaging-based Precision Medicine Task Group of A3 (China-Japan-Korea) Foresight Program Guidelines Open access 03 January 2022 Pages: 895 - 904
Peripheral inflammation is associated with brain SPECT perfusion changes in schizophrenia Guillaume FondAlexandra GarosiEric Guedj Original Article 18 August 2021 Pages: 905 - 912
Similar patterns of [18F]-FDG brain PET hypometabolism in paediatric and adult patients with long COVID: a paediatric case series Aurelie MorandJacques-Yves CampionEric Guedj Original Article 19 August 2021 Pages: 913 - 920
Decrease in the cortex/striatum metabolic ratio on [18F]-FDG PET: a biomarker of autoimmune encephalitis Nicolas De LeirisBerangère RuelEric Guedj Original Article 31 August 2021 Pages: 921 - 931
18F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma Jakoba J. EertinkTim van de BrugJosée M. Zijlstra Original Article Open access 18 August 2021 Pages: 932 - 942
Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements J. J. EertinkA. I. J. Arensthe HOVON imaging workgroup Original Article Open access 02 September 2021 Pages: 943 - 952
[18F]FDG PET-CT in patients with DLBCL treated with CAR-T cell therapy: a practical approach of reporting pre- and post-treatment studies Dan CohenEfrat LuttwakEinat Even-Sapir Original Article 04 September 2021 Pages: 953 - 962
The potential utility of [68 Ga]Ga-DOTA-FAPI-04 as a novel broad-spectrum oncological and non-oncological imaging agent—comparison with [18F]FDG Lianjun LanHanxiang LiuLin Qiu Original Article 19 August 2021 Pages: 963 - 979
Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma Shan-Shan YangYi-Shan WuFang-Yun Xie Original Article Open access 01 September 2021 Pages: 980 - 991
Comparison of nodal staging between CT, MRI, and [18F]-FDG PET/MRI in patients with newly diagnosed breast cancer Janna MorawitzNils-Martin BruckmannJulian Kirchner Original Article Open access 03 September 2021 Pages: 992 - 1001
Investigating ultra-low-dose total-body [18F]-FDG PET/CT in colorectal cancer: initial experience Hui TanDanjie CaiHongcheng Shi Original Article 30 August 2021 Pages: 1002 - 1011
Influence of sarcopenia, clinical data, and 2-[18F] FDG PET/CT in outcome prediction of patients with early-stage adenocarcinoma esophageal cancer Reut AnconinaClaudia OrtegaPatrick Veit-Haibach Original Article 07 September 2021 Pages: 1012 - 1020
68Ga-PSMA PET in prostate cancer: a systematic review and meta-analysis of the observer agreement Mohammadreza ChavoshiSeyed Ali MirshahvaladPatrick Veit-Haibach Review Article 12 November 2021 Pages: 1021 - 1029
68Ga-labeled ODAP-Urea-based PSMA agents in prostate cancer: first-in-human imaging of an optimized agent Xiaojiang DuanZhen CaoXing Yang Original Article 28 August 2021 Pages: 1030 - 1040
Analytical performance of aPROMISE: automated anatomic contextualization, detection, and quantification of [18F]DCFPyL (PSMA) imaging for standardized reporting Kerstin JohnssonJohan BrynolfssonAseem Anand Original Article Open access 31 August 2021 Pages: 1041 - 1051
Head-to-head comparison of [68 Ga]Ga-P16-093 and [68 Ga]Ga-PSMA-617 in dynamic PET/CT evaluation of the same group of recurrent prostate cancer patients Guochang WangHaiyan HongHank F. Kung Original Article 23 September 2021 Pages: 1052 - 1062
The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study) Matteo BaucknehtSara Elena RebuzziGiuseppe Fornarini Original Article Open access 06 September 2021 Pages: 1063 - 1074
177 Lu-PSMA-617 radioligand therapy of metastatic castration-resistant prostate cancer: Initial 254-patient results from a prospective registry (REALITY Study) Fadi KhreishZaidoon GhazalSamer Ezziddin Original Article Open access 07 September 2021 Pages: 1075 - 1085
Vasculitis and bursitis on [18F]FDG-PET/CT following COVID-19 mRNA vaccine: post hoc ergo propter hoc? Jan-Henning Schierz Christine MerkelFarzana Ali Image of the Month 08 September 2021 Pages: 1086 - 1087
High 68 Ga-FAPI-46 uptake in a pulmonary necrotizing granuloma in a patient with subcutaneous lipoma Masatoshi HottaMatthias R. BenzJeremie Calais Image of the Month 21 September 2021 Pages: 1088 - 1089
2-[18F]FDG-PET/CT for early response and brain metabolic pattern assessment after CAR-T cell therapy in a diffuse large B cell lymphoma patient with ICANS Andrea PaccagnellaAndrea FarolfiStefano Fanti Image of the Month 22 September 2021 Pages: 1090 - 1091